selenocystine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhari, P; Epari, S; Gandhi, KA; Gandhi, VV; Goda, JS; Gota, V; Jain, VK; Joshi, K; Kembhavi, S; Kunwar, A; Mohanty, B; Priyadarsini, KI; Rane, S; Sadanpurwala, A | 1 |
| Fu, X; Hou, Y; Li, D; Sun, J; Wei, Z; Zhao, M | 1 |
2 other study(ies) available for selenocystine and Disease Models, Animal
| Article | Year |
|---|---|
Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis.
Topics: A549 Cells; Administration, Oral; Animals; Cystine; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-17; Lung; Lung Neoplasms; Mice; Neutrophils; NF-kappa B; Organoselenium Compounds; Pneumonia; Propionates; Radiation Injuries; Selenium Compounds; Signal Transduction | 2019 |
Selenocystine inhibits JEG-3 cell growth
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Choriocarcinoma; Cystine; Disease Models, Animal; Female; Humans; Mice; Organoselenium Compounds; Oxidative Stress; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Xenograft Model Antitumor Assays | 2018 |